Notable Labs PE Ratio 2013-2024 | NTBLQ
Current and historical p/e ratio for Notable Labs (NTBLQ) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Notable Labs PE ratio as of October 24, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Notable Labs PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-10-22 |
0.25 |
|
0.00 |
| 2024-06-30 |
0.63 |
$-1.45 |
0.00 |
| 2024-03-31 |
1.77 |
$-1.25 |
0.00 |
| 2023-12-31 |
1.89 |
$-1.88 |
0.00 |
| 2023-09-30 |
8.55 |
$-3.63 |
0.00 |
| 2023-06-30 |
8.05 |
$-7.34 |
0.00 |
| 2023-03-31 |
5.86 |
$-11.19 |
0.00 |
| 2022-12-31 |
4.20 |
$-14.69 |
0.00 |
| 2022-09-30 |
5.44 |
$-17.13 |
0.00 |
| 2022-06-30 |
56.35 |
$-16.08 |
0.00 |
| 2022-03-31 |
59.15 |
$-16.08 |
0.00 |
| 2021-12-31 |
68.95 |
$-15.73 |
0.00 |
| 2021-09-30 |
71.75 |
$-16.78 |
0.00 |
| 2021-06-30 |
83.65 |
$-17.83 |
0.00 |
| 2021-03-31 |
70.00 |
$-18.53 |
0.00 |
| 2020-12-31 |
66.15 |
$-19.58 |
0.00 |
| 2020-09-30 |
42.70 |
$-19.93 |
0.00 |
| 2020-06-30 |
44.80 |
$-20.63 |
0.00 |
| 2020-03-31 |
47.25 |
$-20.28 |
0.00 |
| 2019-12-31 |
42.00 |
$-19.23 |
0.00 |
| 2019-09-30 |
47.25 |
$-17.13 |
0.00 |
| 2019-06-30 |
45.50 |
$-17.48 |
0.00 |
| 2019-03-31 |
53.20 |
$-17.48 |
0.00 |
| 2018-12-31 |
33.95 |
$-21.68 |
0.00 |
| 2018-09-30 |
56.88 |
$-9.79 |
0.00 |
| 2018-06-30 |
77.00 |
$-12.94 |
0.00 |
| 2018-03-31 |
80.50 |
$-14.69 |
0.00 |
| 2017-12-31 |
248.50 |
$-12.94 |
0.00 |
| 2017-09-30 |
213.50 |
$-27.62 |
0.00 |
| 2017-06-30 |
155.75 |
$-23.43 |
0.00 |
| 2017-03-31 |
192.50 |
$-22.03 |
0.00 |
| 2016-12-31 |
169.75 |
$-22.73 |
0.00 |
| 2016-09-30 |
182.70 |
$-21.33 |
0.00 |
| 2016-06-30 |
161.35 |
$-27.27 |
0.00 |
| 2016-03-31 |
121.80 |
$-27.62 |
0.00 |
| 2015-12-31 |
184.10 |
$-25.52 |
0.00 |
| 2015-09-30 |
261.80 |
$-20.63 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|
